UCSF Helen Diller Family Comprehensive Cancer Ctr

14.3K posts

UCSF Helen Diller Family Comprehensive Cancer Ctr banner
UCSF Helen Diller Family Comprehensive Cancer Ctr

UCSF Helen Diller Family Comprehensive Cancer Ctr

@UCSFCancer

Championing basic science, clinical research, epidemiology/cancer control, and patient care. Contact: [email protected]

San Francisco Beigetreten Eylül 2011
2.2K Folgt9.7K Follower
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
AACR
AACR@AACR·
The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a cancer diagnosis. Read about the research-driven progress during National Cancer Research Month—#NCRM25: brnw.ch/21wSpgz #UnitedByCancerResearch
AACR tweet media
English
3
13
26
5.4K
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
AACR
AACR@AACR·
May is National Cancer Research Month. Dr. LoRusso, AACR Past President, explains how basic research is essential to accelerating advances in cancer science and medicine. Learn more in the @AACR Cancer Progress Report: brnw.ch/21wSpYt #NCRM25 #UnitedByCancerResaerch
English
0
8
21
2.6K
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
AACR
AACR@AACR·
We thank the more than 22,000 attendees—including more than 900 virtual attendees—from 81 countries who participated in the AACR Annual Meeting 2025 in Chicago. The #AACR25 hashtag garnered 636 million impressions from 3,852 users on X alone.
AACR tweet media
English
3
11
66
7.2K
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
AACR
AACR@AACR·
The 2024-2025 recipients of AACR grants presented their work in a special poster session this evening at #AACR25.
AACR tweet media
English
0
4
20
3.5K
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
Tadashi Manabe MD, PhD
Tadashi Manabe MD, PhD@Tadashi_Manabe·
Successfully presented my research on Exarafenib at #AACR25 today. Grateful to the session chairs for their valuable feedback and support. Looking forward to the future of BRAF-targeted therapies in cancer! #CancerResearch #LungCancer #BRAF
Tadashi Manabe MD, PhD tweet media
English
0
2
7
796
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
Yu-Ting
Yu-Ting@YTChou·
Catch the @BivonaLabUCSF team at #AACR25 on April 29th! @Tadashi_Manabe | 2:30–4:00 PM
Minisymposium, Room S102 @YTChou | 2:00–5:00 PM Section 18, Board 19 Nilanjana Chatterjee | 2:00–5:00 PM
Section 17, Board 5 We’ll be sharing our latest research @UCSFCancer
Yu-Ting tweet media
English
0
1
2
257
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
Ben Huang
Ben Huang@BenHuangLab·
Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML). ascopubs.org/doi/10.1200/JC…
English
1
1
4
313
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
Klebanoff_Lab
Klebanoff_Lab@KlebanoffLab·
🚨🧬Everything you wanted to know about actionable #neoantigens resulting from cancer mutations besides point mutations (*but were afraid to ask). Join us at 10:15 in 📍Room E351 - McCormick Lakeside Center (Level 3)! @MSKCancerCenter @UCSFCancer @institut_curie
Memorial Sloan Kettering Cancer Center@MSKCancerCenter

Join cellular therapist & early drug development specialist Dr. Christopher Klebanoff (@KlebanoffLab) for a symposium titled “Therapeutic targeting of public neoantigens resulting from recurrent gene fusions and mRNA mis-splicing events” today at #AACR25 (@AACR). Learn more: bit.ly/42zjlyF

English
1
3
30
2K
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
UCSF Health
UCSF Health@UCSFHospitals·
UCSF neurosurgery experts including Drs. Shawn @HerveyJumper, @robcosorio, Praveen Mummaneni & Dr. Nima Alan presented new research & clinical findings at the prestigious @AANSNeuro Annual Scientific Meeting in Boston. #AANS2025 Details on their talks ➡️ ucsfh.org/3YjF3UW
UCSF Health tweet media
English
2
5
15
2.1K
UCSF Helen Diller Family Comprehensive Cancer Ctr retweetet
Tadashi Manabe MD, PhD
Tadashi Manabe MD, PhD@Tadashi_Manabe·
Excited to present my research on Exarafenib at #AACR25 tomorrow. My work demonstrates promising efficacy against all classes of BRAF mutations in NSCLC, especially Class 2/3 that lack treatment options. #CancerResearch #BRAF #LungCancer
UCSF Helen Diller Family Comprehensive Cancer Ctr@UCSFCancer

Tuesday, April 29th 2:50 PM CT | @UCSF at #AACR25 | @Tadashi_Manabe @bivonalab presents "Unveiling the potent anti-tumor activity and underlying mechanism of action of the novel pan-RAF inhibitor exarafenib in BRAF-mutated NSCLCr" ow.ly/A3NL50VJheK

English
1
3
10
2.5K